KSP-1007

N/A

Report date: 2025/03/12 16:46:32
NME

Base Information

Drug NameKSP-1007
Drug Alias NameKSP-1007
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics
Mechanisms of ActionBeta Lactamase inhibitors
TargetsBeta Lactamase
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSumitomo DainipponKitasato Institute
China Registration ClassN/A

Develop Information

Active CompaniesSumitomo DainipponSumitovant Biopharma Inc
Inactive CompaniesN/A
Active IndicationsBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A